Dynavax Technologies Stock Current Liabilities

DVAX Stock

USD 12.36 0.19 1.56%

Dynavax Technologies fundamentals help investors to digest information that contributes to Dynavax Technologies' financial success or failures. It also enables traders to predict the movement of Dynavax Stock. The fundamental analysis module provides a way to measure Dynavax Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dynavax Technologies stock.

Total Liab Other Stockholder Equity

Non Current Liabilities Total is likely to rise to about 328.5 M in 2024, whereas Total Current Liabilities is likely to drop slightly above 58.2 M in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Dynavax Technologies Company Current Liabilities Analysis

Dynavax Technologies' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis

Current Dynavax Technologies Current Liabilities

28.79 M

Most of Dynavax Technologies' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dynavax Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Dynavax Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for Dynavax Technologies is extremely important. It helps to project a fair market value of Dynavax Stock properly, considering its historical fundamentals such as Current Liabilities. Since Dynavax Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dynavax Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dynavax Technologies' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Total Current Assets	Net Receivables	Good Will	Intangible Assets	Long Term Debt	Short Term Debt	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.85	-0.49	0.86	0.13	0.8	0.19	0.91	0.62	0.11	0.97	0.84	-0.57	-0.1	0.87	-0.3	0.83	0.78	0.77	0.81	-0.61	0.86	0.9	0.93
Total Stockholder Equity	0.85		-0.21	0.48	0.04	0.96	0.21	0.61	0.2	0.18	0.93	0.59	-0.54	-0.16	0.61	-0.14	0.99	0.59	0.52	0.59	-0.74	0.87	0.94	0.73
Retained Earnings	-0.49	-0.21		-0.63	-0.67	-0.26	0.02	-0.74	-0.39	-0.36	-0.41	-0.41	0.46	-0.1	-0.7	0.7	-0.11	-0.83	-0.74	-0.8	0.12	-0.27	-0.25	-0.57
Total Liab	0.86	0.48	-0.63		0.19	0.43	0.12	0.95	0.85	0.01	0.75	0.84	-0.44	-0.01	0.88	-0.37	0.45	0.74	0.8	0.8	-0.32	0.62	0.61	0.87
Accounts Payable	0.13	0.04	-0.67	0.19		0.17	-0.08	0.36	-0.1	0.54	0.14	-0.03	-0.4	0.15	0.41	-0.42	-0.02	0.55	0.5	0.55	-0.07	0.09	0.06	0.19
Short Term Investments	0.8	0.96	-0.26	0.43	0.17		0.2	0.59	0.07	0.4	0.91	0.44	-0.54	-0.1	0.66	-0.13	0.96	0.6	0.6	0.61	-0.84	0.81	0.94	0.72
Common Stock	0.19	0.21	0.02	0.12	-0.08	0.2		0.09	0.15	-0.01	0.19	0.19	0.5	-0.17	0.09	0.52	0.19	0.05	0.05	-0.03	0.0	0.19	0.12	0.17
Property Plant Equipment	0.91	0.61	-0.74	0.95	0.36	0.59	0.09		0.72	0.15	0.83	0.77	-0.6	-0.09	0.91	-0.48	0.57	0.86	0.84	0.91	-0.47	0.67	0.72	0.9
Current Deferred Revenue	0.62	0.2	-0.39	0.85	-0.1	0.07	0.15	0.72		-0.47	0.46	0.73	-0.15	-0.11	0.51	-0.23	0.18	0.45	0.4	0.49	-0.02	0.36	0.32	0.58
Net Debt	0.11	0.18	-0.36	0.01	0.54	0.4	-0.01	0.15	-0.47		0.2	-0.14	-0.23	0.14	0.46	-0.11	0.18	0.36	0.54	0.36	-0.36	0.18	0.25	0.31
Total Current Assets	0.97	0.93	-0.41	0.75	0.14	0.91	0.19	0.83	0.46	0.2		0.71	-0.59	-0.09	0.82	-0.24	0.92	0.73	0.74	0.76	-0.75	0.87	0.97	0.89
Net Receivables	0.84	0.59	-0.41	0.84	-0.03	0.44	0.19	0.77	0.73	-0.14	0.71		-0.39	-0.12	0.72	-0.25	0.55	0.63	0.59	0.68	-0.14	0.75	0.57	0.81
Good Will	-0.57	-0.54	0.46	-0.44	-0.4	-0.54	0.5	-0.6	-0.15	-0.23	-0.59	-0.39		-0.05	-0.57	0.54	-0.51	-0.53	-0.55	-0.66	0.57	-0.45	-0.59	-0.5
Intangible Assets	-0.1	-0.16	-0.1	-0.01	0.15	-0.1	-0.17	-0.09	-0.11	0.14	-0.09	-0.12	-0.05		0.09	-0.09	-0.15	0.03	0.31	-0.05	0.01	-0.13	-0.11	-0.14
Long Term Debt	0.87	0.61	-0.7	0.88	0.41	0.66	0.09	0.91	0.51	0.46	0.82	0.72	-0.57	0.09		-0.4	0.59	0.85	0.97	0.89	-0.51	0.71	0.74	0.94
Short Term Debt	-0.3	-0.14	0.7	-0.37	-0.42	-0.13	0.52	-0.48	-0.23	-0.11	-0.24	-0.25	0.54	-0.09	-0.4		-0.07	-0.61	-0.41	-0.58	0.05	-0.17	-0.14	-0.31
Net Tangible Assets	0.83	0.99	-0.11	0.45	-0.02	0.96	0.19	0.57	0.18	0.18	0.92	0.55	-0.51	-0.15	0.59	-0.07		0.53	0.49	0.54	-0.77	0.86	0.95	0.71
Capital Surpluse	0.78	0.59	-0.83	0.74	0.55	0.6	0.05	0.86	0.45	0.36	0.73	0.63	-0.53	0.03	0.85	-0.61	0.53		0.83	0.96	-0.31	0.73	0.61	0.84
Deferred Long Term Liab	0.77	0.52	-0.74	0.8	0.5	0.6	0.05	0.84	0.4	0.54	0.74	0.59	-0.55	0.31	0.97	-0.41	0.49	0.83		0.85	-0.49	0.6	0.65	0.83
Long Term Debt Total	0.81	0.59	-0.8	0.8	0.55	0.61	-0.03	0.91	0.49	0.36	0.76	0.68	-0.66	-0.05	0.89	-0.58	0.54	0.96	0.85		-0.37	0.73	0.66	0.88
Short Long Term Debt	-0.61	-0.74	0.12	-0.32	-0.07	-0.84	0.0	-0.47	-0.02	-0.36	-0.75	-0.14	0.57	0.01	-0.51	0.05	-0.77	-0.31	-0.49	-0.37		-0.46	-0.85	-0.5
Net Invested Capital	0.86	0.87	-0.27	0.62	0.09	0.81	0.19	0.67	0.36	0.18	0.87	0.75	-0.45	-0.13	0.71	-0.17	0.86	0.73	0.6	0.73	-0.46		0.85	0.85
Net Working Capital	0.9	0.94	-0.25	0.61	0.06	0.94	0.12	0.72	0.32	0.25	0.97	0.57	-0.59	-0.11	0.74	-0.14	0.95	0.61	0.65	0.66	-0.85	0.85		0.82
Capital Stock	0.93	0.73	-0.57	0.87	0.19	0.72	0.17	0.9	0.58	0.31	0.89	0.81	-0.5	-0.14	0.94	-0.31	0.71	0.84	0.83	0.88	-0.5	0.85	0.82

Click cells to compare fundamentals

Dynavax Current Liabilities Historical Pattern

Today, most investors in Dynavax Technologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Dynavax Technologies' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current liabilities growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Dynavax Technologies current liabilities as a starting point in their analysis.

Dynavax Technologies Current Liabilities

Timeline

Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.

Competition

Predict Dynavax Technologies

Total Current Liabilities Over Time

Dynavax Liabilities And Stockholders Equity

Liabilities And Stockholders Equity

1.05 Billion

At this time, Dynavax Technologies' Liabilities And Stockholders Equity is fairly stable compared to the past year.

In accordance with the recently published financial statements, Dynavax Technologies has a Current Liabilities of 28.79 M. This is 98.36% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 99.64% higher than that of the company.

Dynavax Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dynavax Technologies' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics of similar companies.

Dynavax Technologies is currently under evaluation in current liabilities category among its peers.

Dynavax Technologies ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Dynavax Technologies' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Dynavax Technologies' managers, analysts, and investors.

Environmental

Governance

Social

Dynavax Fundamentals

	Return On Equity	0.0318
	Return On Asset	-0.0038
	Profit Margin	0.08 %
	Operating Margin	0.15 %
	Current Valuation	1.09 B
	Shares Outstanding	131.46 M
	Shares Owned By Insiders	0.33 %
	Shares Owned By Institutions	99.67 %
	Number Of Shares Shorted	18.84 M
	Price To Earning	6.95 X
	Price To Book	2.35 X
	Price To Sales	6.23 X
	Revenue	232.28 M
	Gross Profit	448.22 M
	EBITDA	9.67 M
	Net Income	(6.39 M)
	Cash And Equivalents	518.17 M
	Cash Per Share	4.10 X
	Total Debt	256.91 M
	Debt To Equity	0.61 %
	Current Ratio	2.77 X
	Book Value Per Share	5.19 X
	Cash Flow From Operations	100.56 M
	Short Ratio	8.88 X
	Earnings Per Share	0.15 X
	Target Price	24.6
	Number Of Employees	408
	Beta	1.34
	Market Capitalization	1.62 B
	Total Asset	997.1 M
	Retained Earnings	(930.58 M)
	Working Capital	796.92 M
	Current Asset	199.95 M
	Current Liabilities	28.79 M
	Net Asset	997.1 M

About Dynavax Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dynavax Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC